When a new drug gets tested, the results of the trials should be published for the rest of the medical world — except much of the time, negative or inconclusive findings go unreported, leaving doctors and researchers in the dark. In this impassioned talk, Ben Goldacre explains why these unreported instances of negative data are especially misleading and dangerous.
Positive findings are around twice as likely to be published as negative findings. This is a cancer at the core of evidence-based medicine.
|Still curious? Goldacre is the author of the excellent Bad Science: Quacks, Hacks, and Big Pharma Flacks.|